Eisai Holds Dedication Ceremony to Commemorate New U.S. Corporate Headquarters in Woodcliff Lake, NJ
New Facility Supports Company's Ongoing Expansion and Growth
PRNewswire
WOODCLIFF LAKE, N.J.

Eisai Corporation of North America and Eisai Inc. today hosted a dedication ceremony to commemorate the opening of its newly constructed U.S. corporate headquarters in Woodcliff Lake, NJ. Eisai Corporation of North America, which provides services and oversight to all Eisai U.S. companies, and Eisai Inc., a top-20 U.S. pharmaceutical company, are both subsidiaries of Tokyo-based Eisai Co., Ltd. of Japan.

The three-story, built-to-suit facility provides Eisai with 209,000 square feet of space and capacity for more than 700 people to accommodate its ongoing expansion and anticipated future growth. Eisai's relocation of approximately 300 employees to Woodcliff Lake is one of the largest in Bergen County in more than a decade.

The dedication ceremony was attended by Eisai executives and state and local dignitaries, including Soichi Matsuno, Deputy President and Executive Officer, Eisai Co., Ltd.; Hajime Shimizu, President, Eisai Corporation of North America and Chairman & CEO, Eisai Inc.; and Lonnel Coats, President & COO, Eisai Inc. State and local dignitaries included Jon S. Corzine, Governor, State of New Jersey, and Joe LaPaglia, Mayor, Borough of Woodcliff Lake. Other notable guests included Ambassador Motoatsu Sakurai, Consulate General of Japan in New York; Billy Tauzin, President and CEO, Pharmaceutical Research and Manufacturers of America; and Peter J. Cocoziello, President and CEO, Advance Realty Group.

"It is very rewarding to participate in today's dedication ceremony and to recognize both Eisai Inc. and Eisai Corporation of North America, for which I served as the first Chairman & CEO and President, respectively," said Soichi Matsuno, Deputy President and Executive Officer, Eisai Co., Ltd. "We not only celebrate a new headquarters building but another major milestone in Eisai's history, globalization and achievement of its vision for the U.S. marketplace. In the interest of our human health care mission and the patients and families that we serve, I thank all employees and partners for their valuable contributions to Eisai's success."

"This new office supports other Eisai efforts in the United States, such as Eisai Inc.'s construction of a new 65,000 square-foot facility for future production and R&D formulation of oncology products in Research Triangle Park, NC and the addition of a 150,000 square-foot, basic discovery research facility at Eisai Research Institute of Boston, Inc. in Andover, MA," said Hajime Shimizu, President, Eisai Corporation of North America, and Chairman & CEO, Eisai Inc. "Here in Woodcliff Lake, and through our collaboration with Advance Realty Group, we have created an office building that will successfully meet our workforce and commercial business needs for years to come."

Advance Realty Group of Bedminster, NJ, the property owner and developer, worked closely with Eisai to create the building's neoclassical architectural style and state-of-the-art telecommunications and technology capabilities.

Lonnel Coats, President & COO, Eisai Inc., said, "Our primary goal, as a leading U.S. pharmaceutical company, is to realize our global human health care mission to increase benefits to patients and their families. Both the company and its employees are strongly committed to this, and our new headquarters office supports our efforts. Eisai applauds Advance Realty Group for its dedication, unwavering support and expertise, which ensured the success of our construction and underscored our commitment to Bergen County and the State of New Jersey."

"For more than a decade, Eisai has established a strong presence in the State of New Jersey, providing substantial job opportunities in Bergen County and contributing to the State's economy," said New Jersey Governor Jon S. Corzine. "New Jersey is known as the medicine chest to the world, and Eisai's corporate expansion is a testament to that reputation and to their remarkable success. We're pleased Eisai will grow their business here and will continue to call Bergen County home."

Mayor Joe LaPaglia, Borough of Woodcliff Lake, added, "We welcome Eisai to our important and growing family of area corporate citizens that contribute to the economic health and the quality of life of our community today and beyond."

Eisai, focused on the therapeutic areas of neurology, gastrointestinal disorders and oncology/critical care, is furthering its expansion according to goals set out in its Dramatic Leap Plan for fiscal years 2006-2011 (period ending March 31, 2012). Under this plan, Eisai Co., Ltd. expects to achieve 1,000 billion yen in sales, with Eisai Inc. sustaining double-digit growth in the United States, contributing $4 U.S. billion to worldwide sales and doubling its sales force to approximately 1,500.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with sales of approximately $2.6 billion in fiscal year 2006 (year ended March 31, 2007).

Eisai Inc. employs approximately 1,500 people at its headquarters in Woodcliff Lake, NJ, at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, NC, and in the field. For more information about Eisai, please visit www.eisai.com.

About Advance Realty Group

Advance Realty Group is an owner and developer of office, flex, industrial, retail and multifamily properties. With 5.5 million square feet of operating properties and a development portfolio consisting of eight million square feet of commercial projects and 9,400 residential units, Advance is one of the leading real estate owners in the Northeast and is headquartered in Bedminster, New Jersey. For more information, call Advance Realty Group at (908) 719-3000 or visit www.advancerealtygroup.com.

First Call Analyst:
FCMN Contact:

SOURCE: Eisai Corporation of North America; Eisai Inc.

CONTACT: Sue Yeoh of Chandler Chicco Agency, +1-212-229-8492; or Judee
Shuler, Director, Corporate Planning and Communications of Eisai Inc.,
+1-201-746-2241

Web site: http://www.eisai.com/
http://www.advancerealtygroup.com/

Type Press Release

Date Released October 24, 2007

Tags:

RECENT RELEASES
Mar 5, 2024

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that its U.S. subsidiary Eisai Inc. has decided to invest up to 15 million USD in C2N Diagnostics LLC...

Feb 28, 2024

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the company will present the latest findings on lecanemab (U.S. brand name: LEQEMBI®), Eisai's anti-amyloid beta...

Jan 18, 2024

Data from the Pivotal Phase 3 CLEAR Trial and Phase 2 KEYNOTE-B61 Trial Provide Further Insight into the Role of Lenvatinib Plus Pembrolizumab as a First-Line Treatment Option for Patients with...

Alerts - Release page
SUBSCRIBE TO OUR NEWS
* Required Fields